Tuesday, 28 May, 2024

TB

Most TB patients don't have persistent cough – global study

Experts have found that more than 80% of people in Asia and Africa who have culture-confirmed pulmonary tuberculosis (TB) don’t have persistent coughs –...

New TB drug shows promise in phase 2 trials

The search for better TB drugs got a boost recently with the presentation of promising findings from a study conducted in South Africa on...

SA in five-country trials for drug-resistant TB treatment

South Africans will feature among 300 participants in five-country phase 2 clinical trials for a new drug-resistant, drug-sensitive TB treatment – launched by the...

Even after cure, TB slashes lung function in teens

TB infection can interfere with normal lung development during an important stage of growth – with researchers finding that two out of three teenagers...

Child-friendly TB drug a ‘game-changer’

South African children at high risk of contracting TB could soon benefit from the development of a more palatable and child-friendly regimen, with a...

TB diagnoses reached record high last year – WHO report

Around 7.5m people were diagnosed with TB in 2022, the highest number ever, but this is positive as it shows countries’ ability to detect...

A century of research for TB breakthrough

Although the BCG vaccine for TB has been used for 100 years and is largely effective for children under five, it is less so...

CO2 monitors could protect healthcare staff from TB – SA study

Because of the risk of TB infection through airborne transmission, one way to decrease the chances of this is by improving the ventilation or...

Good diet, social benefits, can halve TB infection – Indian study

Recent research in India found that providing food baskets to people with TB and their households went a long way to preventing and mitigating...

SA in multi-million dollar trial for new TB vaccine

South Africa is among the countries which will take part in a $550m phase three clinical trial of M72, a new candidate vaccine against...

TB fight set back more than a decade because of Covid

The Covid pandemic has set back the fight against TB by about 12 years and led to huge reversals in the decline of cases,...

TB drug costs to drop after J&J loses patent extension bid

People with drug-resistant TB could soon have access to critical medication at a far lower cost after Johnson & Johnson’s application to extend a...

Treatment gaps and poor governance hold back progress in reducing TB

Tuberculosis was declared a global public emergency of international concern 30 years ago, so why are 1.6m people still dying from the disease worldwide...

Community care model improves uptake of TB therapy – KZN study

Tuberculosis (TB) preventive therapy uptake and continuation were much higher when it was provided through a community-based model compared to the standard clinic-based model,...

New TB detection technology speeds up case finding

A new mobile TB detecting clinic using the latest technology has accelerated case finding by two weeks and stands to hugely curb the spread...

MSF trial finds better, shorter, more effective treatment for MDR-TB

The standard-of-care treatments for drug-resistant TB (DR-TB) are nine to 20 months and have side effects that often cause patients to stop taking their...